Genesco stock price target raised to $31 from $25 at Truist Securities

Published 29/08/2025, 14:10
Genesco stock price target raised to $31 from $25 at Truist Securities

Investing.com - Truist Securities raised its price target on Genesco (NYSE:GCO) to $31.00 from $25.00 on Friday, while maintaining a Hold rating on the stock. According to InvestingPro data, analyst targets for the stock range from $29 to $38, with the current price near Fair Value levels. The stock has shown strong momentum, gaining over 8% in the past week.

The firm cited solid momentum in Genesco’s Journeys business, which is experiencing a strong start to the third quarter with double-digit comparable sales growth. This performance builds on double-digit gains from the same period last year, driven by strong back-to-school trends. The company maintains a current ratio of 1.56, indicating sufficient liquidity to meet short-term obligations.

The retailer has raised its full-year revenue guidance based on these positive trends. However, Genesco maintained its previous earnings per share expectations due to gross margin pressures from tariffs and promotional headwinds affecting its Schuh business in the UK.

Truist Securities increased its earnings per share estimates for fiscal years 2026 and 2027 to $1.60 and $2.25, respectively, up from previous estimates of $1.55 and $2.10.

The new price target represents a multiple of 16 times forward twelve-month earnings estimates, up from the previous 15 times multiple, reflecting stronger momentum at Journeys and accounting for a higher market multiple while still maintaining a discount of approximately 30%.

In other recent news, Genesco Inc . reported its second-quarter earnings for 2025, showing a better-than-expected performance despite posting a loss. The company’s adjusted diluted loss per share was $1.14, surpassing analyst expectations of a $1.25 loss. Revenue came in at $546 million, exceeding the forecasted $532.4 million. Jefferies responded to this performance by raising its price target for Genesco to $29 from $24, while maintaining a Hold rating on the stock. The firm noted that Genesco had delivered "another solid quarter" with its fourth consecutive period of positive comparable sales. These developments come amid broader challenges and concerns about the future outlook. Investors remain attentive to how the company navigates these challenges moving forward.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.